Dr. Helen Hasapopoulou has been working in the Thalassaemia and
Sickle Unit of the AHEPA University Hospital since 1988, performing laboratory and
educational work in the blood bank of the hospital. In collaboration with the Department
of Internal Medicine she advises on the care of hospitalised patients with haemoglobinopathies
or auto- and/or allo-immune haemolysis. Dr. Hasapopoulou has been treating a large
cohort of patients with sickle cell disease on small doses of hydroxyurea since
1995. She has further initiated original work on thrombotic complications, on pulmonary
hypertension and its treatment with the investigational drug bosentan, on markers
of oxidative stress, on predictors of cardiac morbidity and mortality, on pegylated
interferon in HCV, on nutrition, on systematic use of laboratory leukoreduction
filters, on the use of magnetic resonance imaging of heart and liver for quantitative
assessment of iron overload, and others.